Stories about Patient
- more
New report from FDI World Dental Federation tackles oral health inequalities and outlines strategies to improve oral healthcare over the next ten years
morePHASE II RESEARCH AGAINST COVID-19 LAUNCHED IN FRANCE WITH DEBIOPHARM’S ANTIVIRAL ALISPORIVIR
moreMerger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
moreNUCLEAI AND DEBIOPHARM LAUNCH RESEARCH COLLABORATION UTILIZING NUCLEAI’S AI-POWERED BIOMARKER PLATFORM
moreFlorian Dieckmann new VP Global Communications at Grünenthal
moreCOVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease
moreCeramTec Group acquires Dentalpoint AG to expand its ceramic Medtech leadership
moreTechnische Universität München
Artificial intelligence improves accuracy: self-learning algorithms analyze medical imaging data
moreTechnische Universität München
Breathing rate predicts therapeutic benefits for heart patients
moreServier to Acquire Agios Pharmaceuticals' Oncology Business
moreBosch Healthcare Solutions GmbH
Bosch's rapid coronavirus test delivers results for positive samples in less than 30 minutes
morePeripheral NOP agonist addressing chronic peripheral neuropathic pain enters clinical development
moreConduent Seamless® Transportation System Now Allows Passengers in France's Tours Métropole Urban Area to Use Their Smartphone for Contactless Payments
moreFresenius Kabi Deutschland GmbH
High prevalence of hospital malnutrition associated with poor clinical outcomes
moreTechnische Universität München
"The machine as extension of the body"
moreSTADA extends ViruProtect partnership with Enzymatica to cover Nordic region
One documentmoreSTADA extends ViruProtect partnership with Enzymatica to cover Nordic region
One documentmoreGerresheimer: On the path to sustainable profitable growth
One documentmoreFrost & Sullivan honours Syntellix with 2020 Best Practices Award, names Syntellix "European Entrepreneurial Company of the Year"
moreNovaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
moreSIFI Press & Communication Office
SIFI appoints Jelle Kleijn as Global Head of Acanthamoeba Keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection
moreSysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia
moreNew study: Only reliable rapid corona tests make sense
moreBD (Becton, Dickinson and Company)
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years
moreGrünenthal agrees to acquire European rights to CRESTOR [TM] (rosuvastatin) from AstraZeneca
moreNorgine B.V. Announces New European Healthcare Subsidiary To Strengthen Its Consumer Healthcare Portfolio
moreEuropean Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
moreCommemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
One documentmoreFresenius Kabi Deutschland GmbH
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition
more
12345678910Next